Evidence map›Paper›PMID 30972832›Full record

ArticleJournal of veterinary internal medicine2019

Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.

Melody A de Laat, Dania B Reiche, Martin N Sillence, James M McGree

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Effect of sirolimus on insulin dynamics in horses.Journal of veterinary internal medicine · 2023
    Article
  7. Impacts of Adiposity on Exercise Performance in Horses.Animals : an open access journal from MDPI · 2023
    Review
  8. Article
  9. Observational
  10. Regenerative Medicine for Equine Musculoskeletal Diseases.Animals : an open access journal from MDPI · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Melody A de LaatScience and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0001-7922-3642
Dania B ReicheAnimal Health, Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
Martin N SillenceScience and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia.
James M McGreeScience and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia.
Queensland University of Technology · AUBoehringer Ingelheim (Germany) · DE

Funding

Boehringer Ingelheim
6 · The paper itself

Abstract

backgroundEndocrinopathic laminitis is common in horses and ponies, but the recurrence rate of the disease is poorly defined.

objectivesTo determine the incidence of, and risk factors for, the recurrence of endocrinopathic laminitis. ANIMALS: Privately owned horses and ponies with acute laminitis (n = 317, of which 276 cases with endocrinopathic laminitis were followed up to study completion).

methodsThis prospective cohort study collected data on veterinary-diagnosed cases of acute laminitis for 2 years. Each case was classified on acceptance to the study as endocrinopathic or non-endocrinopathic using data collected in a questionnaire completed by the animal's veterinarian. Follow-up data were collected at regular intervals to determine whether the laminitis recurred in the 2-year period after diagnosis.

resultsThe recurrence rate for endocrinopathic laminitis was 34.1%. The risk of recurrence during the 2-year study period increased with basal, fasted serum insulin concentration (P ≤ .05), with the probability of recurrence increasing markedly as the insulin concentration increased beyond the normal range (0-20 μIU/mL) to over the threshold for normal (up to approximately 45 μIU/mL). Being previously diagnosed with laminitis (before the study; P = .05) was also a risk factor for recurrent laminitis. Cases with a higher Obel grade of laminitis were likely (P = .05) to recur sooner. CONCLUSIONS AND CLINICAL IMPORTANCE: Knowing that hyperinsulinemia and being previously diagnosed with laminitis are significant risk factors for recurrence will enable clinicians to proactively address these factors, thereby potentially reducing the risk of recurrence of laminitis.

Indexed as

Hoof and ClawAnimalsCohort StudiesEndocrine System DiseasesFemaleFoot DiseasesHorse DiseasesHorsesHyperinsulinismIncidenceMaleProspective StudiesRecurrenceRisk FactorsACTHequine metabolic syndromehorsehyperinsulinemiainsulin dysregulationpituitary pars intermedia dysfunction

Identifiers

PMID30972832
PMCPMC6524073
OpenAlexW2940054686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.